https://www.selleckchem.com/pr....oducts/oprozomib-onx
© 2020 Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.Background and purpose Current practice in re-irradiation (reRT) of previously treated high-grade gliomas (HGG) has generally been limited to small volume reRT with stereotactic procedures. Less evidence exists for large volume reRT involving treatment volumes equivalent to that used at initial diagnosis. The primary aim of this study was to investigate the outcome of large volume reRT delivered in combination with Bevacizumab (BEV)
Like
Comment
Share
